Showing results (871-880 of 2,511) with videos related to

Sort By:
Pageof 252
The Journal of the American Academy of Orthopaedic Surgeons|February 2, 2023
Comorbidity, Racial, and Socioeconomic Disparities in Total Knee and Hip Arthroplasty at High Versus Low-Volume CentersAbdul K Zalikha, Tarek Almsaddi, Fong Nham, et al.
Arthroplasty (London, England)|February 27, 2023
Cannabis use disorder is associated with shorter length of stay and increased home discharge after primary total joint arthroplasty: a propensity-weighted analysisDalia Rahmon, Abdul Kareem Zalikha, Matthew Mazur, et al.
Clinical Genitourinary Cancer|May 10, 2023
Modified GLIM Status as a Predictor of Morbidity and Mortality After Radical Cystectomy: A Propensity Matched AnalysisElia Abou Chawareb, Christian H Ayoub, Adnan El-Achkar, et al.
Medical Education|August 19, 2025
Visual-spatial abilities enhancement and spatial anatomy learning: A systematic reviewLara Nokovitch, Houssein El Hajj, Sophie Deneuve, et al.
BMC Public Health|April 17, 2025
Occupational injury severity among healthcare workers: a retrospective studyGhassan M Khairallah, Samar Al-Hajj, Hani Mowafi, et al.
Neurosurgery|December 19, 2025
Evolution of Patient-Reported Outcome Measures After Surgery for Degenerative Cervical Spine Disease: Do 1-year PROMs Reflect Longer Term Outcomes?Victor Gabriel El-Hajj, Cecilia Kjaerbeck, Victor E Staartjes, et al.
International Journal of Molecular Sciences|December 9, 2023
Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular CarcinomaPerla Chami, Youssef Diab, Danny N Khalil, et al.
Journal of Medicinal Chemistry|November 5, 1997
6 beta-Propynyl-substituted steroids: mechanism-based enzyme-activated irreversible inhibitors of aromataseA Akkani, G Paterlini, W B Gleason, et al.
Cancer Research|September 1, 1983
Detection of a Mr 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodiesD J Adams, H Hajj, D P Edwards, et al.
Anti-Cancer Drugs|August 31, 2006
Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three casesNagi S El-Saghir, Ihab I El-Hajj, Jawad A Makarem, et al.
Pageof 252